Keros Therapeutics Inc (KROS)
58.12
-0.56
(-0.95%)
USD |
NASDAQ |
May 08, 16:00
58.12
0.00 (0.00%)
After-Hours: 16:38
Keros Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 86.21% |
Scholar Rock Holding Corp | -- |
Morphic Holding Inc | -- |
NovaBay Pharmaceuticals Inc | 48.70% |
Palatin Technologies Inc | 95.20% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -48.21% |
Return on Assets | -43.87% |
Return on Invested Capital | -48.21% |
Profit Margin (Quarterly) | -28.14K% |
Operating Margin (Quarterly) | -30.81K% |
Return on Net Operating Assets | -495.3% |